FLT3

FLT3(Fms 样酪氨酸激酶 3,CD135)是一种由 FLT3 基因编码的人类蛋白质。FLT3 是一种细胞因子受体,属于受体酪氨酸激酶 III 类。FLT3 是细胞因子 Flt3 配体 (FLT3L) 的受体。FLT-3 在许多造血祖细胞表面表达。FLT3 的信号传导对于造血干细胞和祖细胞的正常发育非常重要。FLT3 基因是急性髓系白血病 (AML) 中最常见的突变基因之一。此外,据报道,一些没有 FLT3 突变的 AML 患者的原始细胞中野生型 FLT3 水平较高。这些高水平可能与预后较差有关。通过 FLT3 的信号传导在细胞存活、增殖和分化中发挥作用。FLT3 对淋巴细胞(B 细胞和 T 细胞)的发育很重要,但对其他血细胞的发育并不重要。两种下调 FLT3 活性的细胞因子是 TNF-Alpha 和 TGF-Beta。

FLT3 (Fms-like tyrosine kinase 3, CD135) is a protein that in humans is encoded by the FLT3 gene. FLT3 is a cytokine receptor which belongs to the receptor tyrosine kinase class III. FLT3 is the receptor for the cytokine Flt3 ligand (FLT3L). FLT-3 is expressed on the surface of many hematopoietic progenitor cells. Signalling of FLT3 is important for the normal development of haematopoietic stem cells and progenitor cells. The FLT3 gene is one of the most frequently mutated genes in acute myeloid leukemia (AML). Besides, high levels of wild-type FLT3 have been reported for blast cells of some AML patients without FLT3 mutations. These high levels may be associated with worse prognosis. Signaling through FLT3 plays a role in cell survival, proliferation, and differentiation. FLT3 is important for lymphocyte (B cell and T cell) development, but not for the development of other blood cells. Two cytokines that down modulate FLT3 activity are TNF-Alpha and TGF-Beta.

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
BDT001

BDT001 (Example 1) 是一种选择性 FLT3 受体拮抗剂,可用于疼痛性疾病、癌症和自身免疫性疾病的相关研究。

823837-22-5
Antagonist
BDT001

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础